Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity.

MLA

Copland, Alastair, et al. “Salmonella Cancer Therapy Metabolically Disrupts Tumours at the Collateral Cost of T Cell Immunity.” EMBO Molecular Medicine, vol. 16, no. 12, Dec. 2024, pp. 3057–88. EBSCOhost, https://doi.org/10.1038/s44321-024-00159-2.

APA

Copland, A., Mackie, G. M., Scarfe, L., Jinks, E., Lecky, D. A. J., Gudgeon, N., McQuade, R., Ono, M., Barthel, M., Hardt, W.-D., Ohno, H., Hoevenaar, W. H. M., Dimeloe, S., Bending, D., & Maslowski, K. M. (2024). Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity. EMBO Molecular Medicine, 16(12), 3057–3088. https://doi.org/10.1038/s44321-024-00159-2

Chicago

Copland, Alastair, Gillian M Mackie, Lisa Scarfe, Elizabeth Jinks, David A J Lecky, Nancy Gudgeon, Riahne McQuade, et al. 2024. “Salmonella Cancer Therapy Metabolically Disrupts Tumours at the Collateral Cost of T Cell Immunity.” EMBO Molecular Medicine 16 (12): 3057–88. doi:10.1038/s44321-024-00159-2.